Investor Overview At Gilead we are inspired by the opportunity to address unmet medical needs for patients living with life-threatening diseases around the world. Stock Quote Stock Quote Volume: Jan 23, 2020 9:19 AM EST Latest News January 21, 2020 Gilead Sciences to Release Fourth Quarter and Full Year 2019 Financial Results on Tuesday, February 4, 2020 January 9, 2020 Gilead Sciences Licenses Portfolio of HIV Antibodies From The Rockefeller University December 24, 2019 Gilead and Eisai Enter Into Agreement in Japan for the Co-Promotion of the Investigational Rheumatoid Arthritis Therapy Filgotinib, Pending Regulatory Approval View All Events Feb 4, 2020 at 4:30 PM EST Fourth Quarter 2019 Gilead Sciences Earnings Conference Call Jan 13, 2020 at 9:30 AM PST Gilead Sciences at the 38th Annual J.P. Morgan Healthcare Conference Oct 24, 2019 at 4:30 PM EDT Third Quarter 2019 Gilead Sciences Earnings Conference Call View All
